Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Steve E. Krognes

Steve E. Krognes is recorded as CFO and Board Member at Denali Therapeutics Inc. (DNLI). The proxy statement of Denali Therapeutics Inc. reports total compensation of $4,286,877 for Steve E. Krognes in fiscal 2022, including a base salary of $167,067. Disclosed compensation is on record for 6 fiscal years.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Denali Therapeutics Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 Denali Therapeutics Inc. (DNLI) $167,067 $4,286,877
2021 Denali Therapeutics Inc. (DNLI) $501,150 $6,587,660
2020 Denali Therapeutics Inc. (DNLI) $484,200 $4,266,044
2019 Denali Therapeutics Inc. (DNLI) $470,057 $2,530,685
2018 Denali Therapeutics Inc. (DNLI) $455,260 $4,001,231
2017 Denali Therapeutics Inc. (DNLI) $437,750 $1,166,560

Recent activity

No call appearances or filed executive changes recorded yet.